Clinical Trials Logo

Clinical Trial Summary

The study aim at comparing outcomes from the implementation of various endoscopic closure techniques including stenting and suturing on the healing and resolution of esophageal wall defects.


Clinical Trial Description

Esophageal wall defects are a rare but potentially life-threatening subset of luminal pathology which usually require timely intervention in order to reduce the known associated high morbidity and mortality. These defects can be due to surgical and endoscopic procedures, such as post-operative leaks and fistulas and perforations complicating endoscopic dilation. In addition, defects can occur spontaneously due to Boerhaave's syndrome or following chemoradiation treatments of esophageal or other chest malignancies. Surgical management was historically the mainstay of therapy for these defects with conservative management remaining an alternative in poor surgical candidates. Over the last several years however, interventional endoscopy has played an increasing role in treatment of esophageal wall defects, with endoscopic stenting quickly becoming a viable alternative. Temporary stents including the fully covered self-expandable metal stents (FC-SEMS), partially covered self-expandable metal stents (P-SEMS) and self-expandable plastic stents (SEPS) have all been successfully used and have become increasingly regarded as the new standard of care. Indiana University is a tertiary referral center is a destination for complex thoracic surgery, oncology and esophageal disease referrals. The innovative luminal endoscopy team started employing a several modalities including flexible endoscopic suturing and stenting to close esophageal defects. To our knowledge, there is a dearth of data on outcomes associated with multi-modality esophageal defect closure techniques and little to no data comparing this approach to the current standard of care of stenting alone or surgery. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04571541
Study type Observational
Source Indiana University
Contact Martha Mendez
Email mwmendez@iu.edu
Status Recruiting
Phase
Start date July 1, 2014
Completion date July 1, 2025

See also
  Status Clinical Trial Phase
Completed NCT01900691 - Removal of the Evolution® Esophageal Stent - Fully Covered N/A
Recruiting NCT05606822 - Endoscopic Vacuum Therapy for Transmural Defects in the Upper Gastrointestinal Tract
Withdrawn NCT02751333 - Esophageal Stent Migration With Endoscopic Suture Fixation Compared to Standard Deployment Phase 2
Recruiting NCT05758805 - Esophageal Injury of a Tip CF Sensing Ablation Catheter for HP-SD of Paroxysmal and Persistent AF (ESO-SAFE-HP-RF) N/A
Completed NCT00422760 - A 75 Year Old With Dyspnea a Case Report.Observational Study N/A